Based on form, the eubiotics market share from the dry form segment is anticipated to expand at 6.5% CAGR through 2032, driven to the low storage and transportation costs associates. Dry eubiotics also ensure long shelf life of feed while maintaining its cultural stability as well. The form witnesses a particularly high demand in emerging economies owing to the aforementioned factors and supportive initiatives from various organizations to eliminate risks and keep the food chain from collapsing.
 

Back in December 2021, the Asian Development Bank invested over USD 10 million in Zenex Animal Health, a leading Indian animal health firm, to help it increase the production and distribution of quality animal healthcare products and mitigate livestock disease risk in the region.
 

The eubiotics market size from swine segment is poised to reach USD 720 million by 2032. Pigs are highly susceptible to livestock diseases, which makes them a high-risk investment for farmers. As such, pig farmers put more efforts into ensuring that their livestock lead a healthy life and improve the overall financial performance of the farm. Diseases such as classical swine fever, a highly contagious viral disease that affects pigs, and the infection caused by its less virulent isolates is hard to be examined in older pigs, which makes it pertinent that the animals have good immunity. 
 

The dietary supplementation of probiotics helps improve gut health and nutrient digestibility to benefit the growth performance of pigs. Probiotics also impart diarrhea reduction and antitoxin effects, which favors their adoption. 
 

The eubiotics market share from organic acid segment is estimated to observe around 4% growth rate during the forecast period, led by the product’s antimicrobial and preservative effects. Organic acid-based eubiotics also help enhance growth performance of animals and help achieve optimum gut health, making them highly preferred among farmers. The product helps manage the microflora in animals during stressful conditions as well, creating a strong impetus for segment growth. They further improve animal performance by reducing gastric pH while also enhancing pepsin activity. 
 

On the regional front, the North America eubiotics market is predicted to exhibit a CAGR of 6% during 2023 to 2032, on account of increasing investments towards animal health in the region. Back in December 2021, the US Department of Agriculture’s (USDA) APHIS announced an investment of over USD 16.3 million in 64 projects geared towards animal health protection. 
 

Meanwhile, regional growth can also be ascribed to favorable GRAS approval policies for eubiotics products. Rising consumption of dairy and meat-based food in the region, driven by improved economic scenarios and cost-effectiveness is further escalating the demand for eubiotics.